Atomo Diagnostics (ASX:AT1) EBIT per Share : A$-0.01 (TTM As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Atomo Diagnostics EBIT per Share?

Atomo Diagnostics's EBIT per Share for the six months ended in Jun. 2024 was A$-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was A$-0.01.

During the past 3 years, the average EBIT per Share Growth Rate was 2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Atomo Diagnostics's EBIT per Share or its related term are showing as below:

ASX:AT1' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 1.6 Med: 2.25 Max: 2.9
Current: 2.9

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Atomo Diagnostics was 2.90% per year. The lowest was 1.60% per year. And the median was 2.25% per year.

ASX:AT1's 3-Year EBIT Growth Rate is ranked worse than
54.48% of 714 companies
in the Medical Devices & Instruments industry
Industry Median: 6.95 vs ASX:AT1: 2.90

Atomo Diagnostics's EBIT for the six months ended in Jun. 2024 was A$-3.43 Mil.

Atomo Diagnostics EBIT per Share Historical Data

The historical data trend for Atomo Diagnostics's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atomo Diagnostics EBIT per Share Chart

Atomo Diagnostics Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Jun24

EBIT per Share

-0.01

-0.02

-0.01

Atomo Diagnostics Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT per Share	Get a 7-Day Free Trial					-	-0.01	-0.01	-0.01	-0.01

Atomo Diagnostics EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Atomo Diagnostics's EBIT per Share for the fiscal year that ended in Jun. 2024 is calculated as

	EBIT per Share		(A: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-7.161	/	634.659
=	-0.01

Atomo Diagnostics's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3.43	/	640.477
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01

Atomo Diagnostics (ASX:AT1) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Atomo Diagnostics EBIT per Share Related Terms

Thank you for viewing the detailed overview of Atomo Diagnostics's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Atomo Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Atomo Diagnostics Ltd (ASX:AT1) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040

Website

https://www.atomodiagnostics.com

Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.

Atomo Diagnostics Headlines

No Headlines